Abstract
Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
- Received September 4, 2014.
- Accepted November 10, 2014.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
Editor’s choice – Sporadic amyotrophic lateral sclerosis (SALS) – skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model
Trichur R. Raju and colleagues explore how the pathological changes of the skeletal muscle can significantly damage motor neurons, leading to progressive neurodegeneration in amyotrophic lateral sclerosis.
Catch up with Shruthi Shanmukha, the first author on this paper, in her First Person interview.
Featured article – Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes
An innovative double binary zebrafish model from Tatjana Sauka-Spengler and co-workers allows exploration of the regulatory mechanisms that govern the myeloid response at the onset of melanoma.
DMM in the news – Diabetes-associated pain linked to disrupted insulin signalling
The chronic pain experienced by a number of patients with diabetes has widely been assumed to originate from damage to blood vessels or to local tissue surrounding neurons caused by high blood-sugar levels. However, a new study reports that in fruit flies, this pain hypersensitivity results instead from disrupted insulin signalling in pain sensory neurons.
Review – Animal models for bone tissue engineering and modelling disease
Currently used animal models of critical-sized bone defects and the regenerative bone tissue engineering strategies used in these models are reviewed by Jacqui Anne McGovern, Michelle Griffin and Dietmar Werner Hutmacher, as well as the application of bone tissue engineering for the advancement of cancer xenograft models.
Propose a new Workshop
We are currently seeking proposals for four Workshops to be held in 2020. Do you have an idea for a Workshop? Please let us know and you could be one of our 2020 Workshop organisers. You focus on the science, we focus on the logistics. We are particularly keen to receive proposals from postdocs. Deadline date for applications is 25 May 2018.
Travelling Fellowships – Transfer of experience
Elizabeth Rhea, a postdoctoral fellow at the University of Washington, USA, used a Travelling Fellowship from DMM to travel to Monash University in Melbourne, Australia. There, Elizabeth worked on developing a method to use the buccal mucosa as a model for screening enhancers of intranasal insulin delivery. Read more on her story here.
Where could your research take you? Join Elizabeth and apply for the next round of Travelling Fellowships from DMM by 25 May 2018.
Why should you publish your next paper in DMM?
DMM aims to promote human health by encouraging collaboration between basic and clinical researchers, covering a diverse range of diseases, approaches and models. Our Editors are all active researchers in the field – your peers, colleagues and mentors, who know how much work has gone into every paper. Recently, we have introduced format-free submission, and we accept peer review reports from other journals, making submission as easy as possible for our authors. Send us your next great paper – publish with us and you'll be in good company.
preLights – Preprint highlights, selected by the biological community
preLights is the new preprint highlights service run by the biological community and supported by The Company of Biologists.
Meet the preLighters! In the latest interview with our preLights community, the preLights team caught up with James Gagnon, Assistant Professor at the University of Utah, to talk about his research, how science can be made more open, his enthusiasm for the preLights project and the fun sides of being a junior PI.